← Product Code [FPB](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FPB) · K233277
# Filter Needle for Single Use (K233277)
_Hangzhou Qiantang Longyue Biotechnology Co., Ltd. · FPB · May 10, 2024 · General Hospital · SESE_
**Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FPB/K233277
## Device Facts
- **Applicant:** Hangzhou Qiantang Longyue Biotechnology Co., Ltd.
- **Product Code:** [FPB](/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FPB.md)
- **Decision Date:** May 10, 2024
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 880.5440
- **Device Class:** Class 2
- **Review Panel:** General Hospital
## Indications for Use
This product is intended for the aspiration and preparation of medical fluid, not including injection.
## Device Story
Filter Needle for Single Use is a manual, single-use, irradiation-sterilized device designed for the aspiration, filtration, and preparation of medical fluids. It consists of a cap, needle hub, sheath, needle cannula, and filter. The device features a 6% standard tapered connector (luer taper) for attachment to infusion sets. It is operated manually by healthcare professionals to extract and filter medicinal solutions prior to administration. The device does not perform injections. By filtering fluids, it helps ensure the removal of particulates, potentially benefiting the patient by reducing the risk of infusion-related complications. The device is provided sterile and is intended for prescription use.
## Clinical Evidence
No clinical data. Substantial equivalence is supported by bench testing, including biocompatibility (ISO 10993-1:2018), particulate contamination (ISO 8536-4:2019, USP 788), sterilization validation (ISO 11137), and mechanical performance testing (ISO 7864:2016, ISO 22413:2021). All tests passed.
## Technological Characteristics
Materials: Polycarbonate (PC) hub/cap/sheath, medical stainless steel (SUS304) cannula, polyamide (PA) filter. 6% standard tapered connector (EN ISO 80369-7). Manual operation. Sterilization: Irradiation (SAL 10^-6). Complies with ISO 7864:2016, ISO 22413:2021, ISO 10993-1:2018, and USP <85>.
## Regulatory Identification
An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.
## Special Controls
*Classification.* Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
## Predicate Devices
- B-D FILTER NEEDLE ([K801343](/device/K801343.md))
## Submission Summary (Full Text)
> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains two logos. On the left is the Department of Health & Human Services logo. On the right is the FDA logo, which is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
May 10, 2024
Hangzhou Qiantang Longyue Biotechnology Co., LTD % Esther Zhang Regulatory Affairs Shanghai Ling Fu Technology Co., Ltd. 4F, No.585-2 Wanyuan Road, Minhang District Shanghai, Shanghai 201102 China
Re: K233277
Trade/Device Name: Filter Needle for Single Use Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: Class II Product Code: FPB Dated: April 10, 2024 Received: April 11, 2024
Dear Esther Zhang:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device"
{1}------------------------------------------------
(https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
David Walloschek
David Wolloscheck, Ph.D. Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors
{2}------------------------------------------------
OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
## Indications for Use
510(k) Number (if known) K233277
Device Name Filter Needle for Single Use
Indications for Use (Describe)
This product is intended for the aspiration and preparation of medical fluid, not including injection.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
#### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{4}------------------------------------------------
# K233277_510(k) summary
#### I Submitter
| Device submitter: | Hangzhou Qiantang Longyue Biotechnology Co., LTD
104, 301, 302, building 12, building 1,619 WangMe
Road Linping street, Linping District, Hangzhou |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact person: | Chunyu Wang
Quality Assurance Manager
Phone: 0086-571-89150121
Email: chunyu_wang@nextech-x.com
Fax: 86-571-89150091 |
Prepare Date: May 10, 2024
### II Correspondent
| Company | Shanghai Ling Fu Technology Co., Ltd.
4F, No.585-2 Wanyuan Road, Minhang District, Shanghai
P.R.China |
|-----------------|-------------------------------------------------------------------------------------------------------------|
| Contact person: | Esther ZHANG
Regulatory affairs
Phone: 0086-13771505757
Email: Esther.zhang@llins-tech.com |
## III Device
Trade Name of Device: Filter Needle for Single Use Common Name: Infusion Line Filter Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular administration set Regulatory Class: II Product code: FPB Review Panel: General Hospital
#### IV Predicate Devices
| Trade name: | B-D FILTER NEEDLE |
|-------------------------|-------------------------------------------------------|
| Common name: | Infusion Line Filter |
| Classification: | Class II, 21 CFR 880.5440 |
| Product Code: | FPB |
| Premarket Notification: | K801343 |
| Manufacturer: | BD BECTON DICKINSON VACUTAINER SYSTEMS
PREANALYTIC |
{5}------------------------------------------------
#### V Device description
The Filter Needle for Single Use is a single use, irradiation sterilized device that is designed to be used for use in conjunction with luer taper infusion sets conforming to EN ISO 80369-7 for the extraction, filtration and configuration of medicinal solutions and is not intended for injection purposes. Filter Needle for Single Use consists of cap, needle cannula, needle hub, sheath and filter. The cap, needle hub and sheath are made of polycarbonate (PC), the needle tube is made of medical stainless steel (SUS304), and filter is made of polyamide (PA).
The needle holder is a 6% standard tapered connector with good connectivity to the infusion apparatus.
| Model Number | Description |
|--------------|------------------------|
| FN-B1838RW | 18 Gauge, 38 mm length |
| FN-B1850RW | 18 Gauge, 50 mm length |
| FN-L1938TW | 19 Gauge, 38 mm length |
| FN-L1950TW | 19 Gauge, 50 mm length |
#### VI Indications for use
This product is intended for the aspiration, filtration and preparation of medical fluid, not including injection.
#### VII Comparison of technological characteristics with the predicate devices
The Filter Needle for Single Use has the same intended use, technology, design and performance specifications are either identical or substantially equivalent to existing legally marketed predicate devices. The differences between the Filter Needle for Single Use and predicate devices do not alter suitability of the proposed device for its intended use.
| Device feature | Subject Device | Predicate Device
K801343 | Comments |
|--------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------|
| Product code | FPB | FPB | Identical |
| Regulation
number | 21 CFR 880.5440 | 21 CFR 880.5440 | Identical |
| Class | CLASS II | CLASS II | Identical |
| Number of
uses | Single use Rx only | Single use Rx only | Identical |
| Material | Needle holder material of
polycarbonate
(PC),
needle tube material of
stainless steel (SUS304),
filter membrane material of
polyamide (PA) | Needle holder material
(PC),
Needle tube
material (SUS304),
Filter membrane
material (PA) | Identical |
| Device feature | Subject Device | Predicate Device
K801343 | Comments |
| Sheath | Image: Subject Device Sheath | Image: Predicate Device Sheath | Different
Comment
1 |
| Indications for
Use | This product is intended
for the aspiration, filtration
and preparation of medical
fluid, not including
injection. | The B-D FILTER
NEEDLE is intended
for the aspiration,
filtration and
preparation of medical
fluid, not including
injection. | Identical |
| Operating
principles | Manual | Manual | Identical |
| Design
specifications | Needle Gauge:
18G, 19G
Length:
38 mm,50 mm | Gauge: 18 G
Length (mm): 40
Length (inch): 1 1/2" | Different
Comment
2 |
| Performance | Conforms to the standard
requirements of ISO
7864:2016 and ISO
22413:2021 | Conforms to the
standard requirements
of ISO 7864:2016 and
ISO 22413:2021 | Identical |
| Biocompatibility | Biocompatible
The
finished device's patient
contacting parts were
assessed in accordance
with tests recommended in
the FDA Guidance - Use of
International Standard
ISO-10993- 1, "Biological
evaluation of medical
devices - Part 1:
Evaluation and testing
within a risk management
process." | Biocompatible
The
finished device's
patient contacting parts
were assessed in
accordance with tests
recommended in the
FDA Guidance - Use of
International Standard
ISO-10993- 1,
"Biological evaluation
of medical devices -
Part 1: Evaluation and
testing within a risk
management process." | Identical |
| Sterilization
method | Irradiation sterilization | Irradiation sterilization | Identical |
| Bacterial
endotoxin | USP <85> | USP <85> | Identical |
| Expiration Date | 4 years | 5 years | Different
Comment
3 |
{6}------------------------------------------------
Discussion:
{7}------------------------------------------------
#### Comment 1
Although there are differences in the size and design of the two sheaths of needle, their general forms are essentially the same. Since the structure and intended use of the body of the subject and predicate device remain unchanged, modifications to the sheath do not raise different safety concerns or new ones.
#### Comment 2
Needle length specification our needle length specification is 38mm and 50mm, and BD needle length specification is 40mm. Tests on the varying needle lengths of the subj are performed per ISO 7864:2016. These test results confirm that the differences in needle lengths do not impact the safety or effectiveness.
#### Comment 3
Our products are valid for 4 years and BD' products are valid for 5 years. We have implemented validation of our products, and the safety and validity of our products meet the requirements within the validity period.
In conclusion, there is no substantial difference between our products and similar products currently marketed in the United States.
{8}------------------------------------------------
#### VIII Performance data
The following performance data were provided in support of the substantial equivalence determination.
#### Biocompatibility testing
Biocompatibility of the Filter Needle for Single Use was evaluated in accordance with ISO 10993-1:2018 for the body contact category of "External communication device -Blood path indirect" with a contact duration of "Limited (< 24 hours)". The following tests were performed, as recommended:
| Cytotoxicity | ISO 10993-5: 2009 |
|---------------------------|--------------------|
| Skin sensitization | ISO 10993-10: 2021 |
| Hemolysis | ISO 10993-4: 2017 |
| Intracutaneous reactivity | ISO 10993-23: 2021 |
| Acute systemic toxicity | ISO 10993-11: 2017 |
| Pyrogenicity | ISO 10993-11: 2017 |
In addition to the above tests, particulate contamination was evaluated to ensure compliance with particulate cleanliness requirements. The particulate testing was conducted following:
Particulate Testing Standard: ISO 8536-4:2019 and USP 788.
#### Sterilization and shelf-life testing
The sterilization method has been validated to ISO 11137, which has thereby determined the routine control and monitoring parameters. The sterilization process is validated to a minimum SAL 10-6.
The shelf life of the Filter Needle for Single Use is determined based on stability study which includes ageing test. The testing is performed according to the following standards:
- ISO 11607-1: 2019 Packaging for terminally sterilized medical devices Part 1: A Requirements for materials, sterile barrier systems and packaging systems
- A ISO 11607-2: 2019 Packaging for terminally sterilized medical devices - Part 2: Validation requirements for forming, sealing and assembly processes
- A ASTM F1980-21 Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices
- > ASTM F1929-2015 Standard Test Method for Detecting Seal Leaks in Porous Medical Packaging by Dye Penetration
- A ASTM D4169-22 Standard Practice for Performance Testing of Shipping Containers and Systems
{9}------------------------------------------------
#### Performance testing
| Performance testing Summary | | | |
|-----------------------------|-----------------------------------|----------------------------|--------|
| Number | Item | Testing standard | Result |
| 1. | Exterior Condition | ISO 7864:2016 | Pass |
| 2. | Needle Length | ISO 7864:2016 | Pass |
| 3. | Needle Holder
Tapered Fittings | ISO 7864:2016 | Pass |
| 4. | Uprightness | ISO 7864:2016 | Pass |
| 5. | Firmness of
Connection | ISO 7864:2016 | Pass |
| 6. | Particulate
Contamination | ISO 22413-2021 | Pass |
| 7. | Tightness | ISO 22413-2021 | Pass |
| 8. | Piercing Force | ISO 22413-2021 | Pass |
| 9. | Puncture Chip | ISO 22413-2021 | Pass |
| 10. | Filtration Rate | ISO 22413-2021 | Pass |
| 11. | Seat to Sheath
Mating | ISO 7864:2016 | Pass |
| 12. | Chemical Property | ISO 7864:2016 | Pass |
| 13. | Sterility | United States Pharmacopeia | Pass |
| 14. | Bacterial Endotoxin | USP <85> | Pass |
### IX Conclusion
The Filter Needle for Single Use are substantially equivalent to its predicate device (B-D FILTER NEEDLE). The non-clinical testing demonstrates that the device is as safe and as effective as the legally marketed predicate device.
---
**Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FPB/K233277](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94general-hospital-and-personal-use-therapeutic-devices/FPB/K233277)
**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).
**Cite:** Innolitics at https://innolitics.com